Fools think vaccine series at $100-1000/each per person per lifetime is where the money get made....
When I see the Breztri has 120 doses/device I already know what the dose is going to be:
The usual Breztri Aerosphere dosage for adults with COPD is 2 puffs (sprays) twice per day.
4 doses/day x 30 days = 120/device ; $676 = 1 month supply
= $8112/year
In the marketing materials the largest number 52% is attribute to "one study of people with COPD,† most of whom did not have a history of flare-ups in the last year". So people who are not really very sick, if you can get them started on some med now they could be on it for 10 or 20 years! Others will get added along the way so this cost will be double, trippled, etc; and this for just ONE disease.
So basically the way these things work is they don't necessarily get a patent on any actual new drugs, you can use any old drugs. (Sometimes they make new drug though.) They make the little plasticdoohicky you squeeze to get the medication, and the mix of medications. (This is a very rudimentary understanding, please correct me if you know better details.)
Under communism, the plastic doohickies should be reusable and refillable.
No you've pretty much got the gist of it. They can get a new patent on a new formulation (aerosol vs powder vs aerosphere) on the same medications. The same thing they do with capsules, tablets, ER tablets, ER capsules, solutions, suspensions, granules, injections, patches, you can go on. Same med, same effect, minimal new R&D needed compared to developing and testing a whole new drug, and cash in on an exclusive patent for 10ish years.
It's crazy how each substantially similar innovation arrives about 9ish years after the last one. Must be the natural cycle of drug research?
Not that there would be any generic manufacturers chomping at the bit to make the doohickies anyway. Think of the insulin or epinephrine pens. Drugs are cheap. Doohicky is expensive. Probably all sorts of regulations, certifications etc related to manufacturing them not to mention distribution channels, insurance coverageand who knows what barriers.
these people who think vaccines are such bigtime money makers have never even heard of breo
Check out the prices on some of the newer ones, Bevespi for example
Or Breztri holy shit
Fools think vaccine series at $100-1000/each per person per lifetime is where the money get made....
When I see the Breztri has 120 doses/device I already know what the dose is going to be:
4 doses/day x 30 days = 120/device ; $676 = 1 month supply
= $8112/year
In the marketing materials the largest number 52% is attribute to "one study of people with COPD,† most of whom did not have a history of flare-ups in the last year". So people who are not really very sick, if you can get them started on some med now they could be on it for 10 or 20 years! Others will get added along the way so this cost will be double, trippled, etc; and this for just ONE disease.
So basically the way these things work is they don't necessarily get a patent on any actual new drugs, you can use any old drugs. (Sometimes they make new drug though.) They make the little plasticdoohicky you squeeze to get the medication, and the mix of medications. (This is a very rudimentary understanding, please correct me if you know better details.)
Under communism, the plastic doohickies should be reusable and refillable.
No you've pretty much got the gist of it. They can get a new patent on a new formulation (aerosol vs powder vs aerosphere) on the same medications. The same thing they do with capsules, tablets, ER tablets, ER capsules, solutions, suspensions, granules, injections, patches, you can go on. Same med, same effect, minimal new R&D needed compared to developing and testing a whole new drug, and cash in on an exclusive patent for 10ish years.
It's crazy how each substantially similar innovation arrives about 9ish years after the last one. Must be the natural cycle of drug research?
Not that there would be any generic manufacturers chomping at the bit to make the doohickies anyway. Think of the insulin or epinephrine pens. Drugs are cheap. Doohicky is expensive. Probably all sorts of regulations, certifications etc related to manufacturing them not to mention distribution channels, insurance coverageand who knows what barriers.